Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

746
Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
746
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

511
Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
511

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Sham tDCS: A hidden source of variability? Reflections for further blinded, controlled trials.

Brain stimulation·2019
Same author

Author Response: Exercise for cognitive brain health in aging: A systematic review for an evaluation of dose.

Neurology. Clinical practice·2018
Same author

Prevention of Early Postoperative Decline (PEaPoD): protocol for a randomized, controlled feasibility trial.

Trials·2018
Same author

Challenges of differential placebo effects in contemporary medicine: The example of brain stimulation.

Annals of neurology·2018
Same author

The Role of Cognitive Reserve in Alzheimer's Disease and Aging: A Multi-Modal Imaging Review.

Journal of Alzheimer's disease : JAD·2018
Same author

Age-related differences in default-mode network connectivity in response to intermittent theta-burst stimulation and its relationships with maintained cognition and brain integrity in healthy aging.

NeuroImage·2018
Same journal

Evidence for progressive neurodegeneration in iatrogenic cerebral amyloid angiopathy.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026
Same journal

Human brain connectome profiles mediate the relationship between pathology burden and clinical phenotypes in Alzheimer's disease.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026
Same journal

Kat5 cKO mouse replicates biological domain signatures associated with Alzheimer's disease.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026
Same journal

Evaluation of CSF and plasma tau species as fluid surrogate candidates for tau PET in prodromal to moderate Alzheimer's disease.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026
Same journal

Associations of self-reported obstructive sleep apnea with cognition and dementia risk in cognitively unimpaired middle-aged adults.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026
Same journal

Inflammation profiles in Alzheimer's disease relate to cognition and neurodegeneration.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026
查看所有相关文章

相关实验视频

Updated: Jan 7, 2026

Dried Blood Spot Collection of Health Biomarkers to Maximize Participation in Population Studies
07:20

Dried Blood Spot Collection of Health Biomarkers to Maximize Participation in Population Studies

Published on: January 28, 2014

37.1K

生物标志物 生物标志物

Tanya Talkar1, Daniel J Schulman1, David J Libon2,3,4

  • 1Linus Health, Boston, MA, USA.

Alzheimer's & dementia : the journal of the Alzheimer's Association
|December 26, 2025
PubMed
概括
此摘要是机器生成的。

远程数字认知评估 (rDAC) 通过基于iPad的测试有效地识别认知障碍 (CI). 这种工具对早期检测诸如轻度认知障碍 (MCI) 和痴呆症等疾病充满希望.

更多相关视频

Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances
07:35

Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances

Published on: October 11, 2018

7.9K
Ecotoxicological Methodologies to Evaluate Biomarkers at Different Scales in Neotropical Anurans
08:14

Ecotoxicological Methodologies to Evaluate Biomarkers at Different Scales in Neotropical Anurans

Published on: April 28, 2023

699

相关实验视频

Last Updated: Jan 7, 2026

Dried Blood Spot Collection of Health Biomarkers to Maximize Participation in Population Studies
07:20

Dried Blood Spot Collection of Health Biomarkers to Maximize Participation in Population Studies

Published on: January 28, 2014

37.1K
Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances
07:35

Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances

Published on: October 11, 2018

7.9K
Ecotoxicological Methodologies to Evaluate Biomarkers at Different Scales in Neotropical Anurans
08:14

Ecotoxicological Methodologies to Evaluate Biomarkers at Different Scales in Neotropical Anurans

Published on: April 28, 2023

699

科学领域:

  • 神经科学和认知科学 神经科学和认知科学
  • 数字健康和医疗技术数字化
  • 老年学和衰老研究研究.

背景情况:

  • 目前对轻度认知障碍 (MCI) 和阿尔茨海默病 (AD) 导致的痴呆症的诊断标准需要记录认知障碍 (CI).
  • 传统的神经心理测试虽然严格,但存在很大的时间障碍,可能会推迟早期CI检测和获得治疗的机会.
  • 本研究探讨了一种新的远程数字认知评估 (rDAC) 的实用性,用于识别CI.

研究的目的:

  • 评估rDAC在区分认知不受损 (CU) 个体,MCI个体和痴呆症个体之间的有效性.
  • 评估从rDAC自动提取的传统,过程和声学指标的诊断性能.
  • 确定rDAC是否可以作为早期认知障碍检测的可行,可访问的工具.

主要方法:

  • 通过iPad进行的rDAC包括口头学习测试,语义流性和数字跨度测试.
  • 根据综合评估,参与者被分类为认知无障碍 (CU,n=24),MCI (n=42) 或痴呆症 (n=15).
  • 随机森林模型经过训练,将参与者分为不同的认知状态组 (例如,CU与MCI,CU与痴呆症).

主要成果:

  • 在区分CU和MCI (AUC=0.95,精度=0.87) 方面取得了高精度.
  • 在检测任何CI (CU与MCI+痴呆症) 中观察到出色的性能,AUC=0.98和精度=0.91.
  • 关键的区分特征包括语音发音速率,暂停时间和声学语音特性 (动,持续时间).

结论:

  • 简要的,基于iPad的rDAC展示了作为标志着早期认知障碍的敏感工具的巨大潜力.
  • rDAC的性能与传统的,耗时的神经心理测试方法相美.
  • 在rDAC中整合结果,流程和声学指标有效地捕捉了暗示CI的微妙性能差异.